ABSTRACT
Loss of ion homeostasis plays a central role in pathogenesis of ischemic cell damage. Ischemia-induced perturbation of ion homeostasis leads to intracellular accumulation of Ca 2+ and Na + and subsequent activation of proteases, phospholipases, and formation of oxygen and nitrogen free radicals. This signal transduction cascade results in long-term functional and structural changes in membrane and cytoskeletal integrity and eventual cell death (1) . Both ion conductances and ion transporters could affect ion homeostasis. Considerable research effort has been centered on roles of passive fluxes via cation and anion conductances in cerebral ischemic damage. This review will instead focus on the recent studies into the role of secondary active transport proteins in ischemia-induced dissipation of ion homeostasis. Secondary a ctive ion transport proteins are a membrane protein-mediated solute transport mechanism that derives its energy from the combined chemical gradients of the transported ions. They are important in maintaining steady-state intracellular ion concentrations. These include Na + -dependent chloride transport (NKCC), Na + /H + exchange (NHE), and Na + /Ca 2+ exchange (NCX). Results from both in vitro and in vivo experimental studies suggest that these ion transport proteins are potential targets to reduce or prevent ischemiamediated loss of ion homeostasis.
INTRODUCTION
Loss of ion homeostasis plays a central role in pathogenesis of ischemic cell damage. Ischemic-induced perturbation of ion homeostasis leads to intracellular accumulation of Ca 2+ and Na + and subsequent activation of proteases, phospholipases, and formation of oxygen and nitrogen free radicals. This cascade of signal transduction events result in long-term functional and structural changes in membrane and cytoskeletal integrity and eventual cell death (1, 2) . Normally, the physiologically important ions (Na + , Ca 2+ , Cl -) are not in electrochemical equilibrium across the plasma membrane.
Their gradients are maintained by two major primary active transport proteins Na + /K + -ATPase and Ca 2+ -ATPase. Primary active transport systems expends metabolic energy in ATP to transport specific ions against their concentration or electrochemical gradients.
For each ATP molecule hydrolyzed, Na + /K + -ATPase usually drives 3 Na + ions out of cells and two K + ions in. The Ca 2+ -ATPase provides the primary mechanism for removing Ca 2+ from the cell. The activity of these pumps results in an extracellular fluid high in Na + (~ 145 mM) , Cl -(~ 100 mM) and Ca 2+ (~2 mM), but low in K + [~ 4.5 mM, (3) ]. In contrast, the intracellular fluid is low in Na + (~10-15 mM), Cl -(6-40 mM), and Ca 2+ (< 10 -7 M), but high in K + (~ 150 mM).
Secondary active ion transport proteins do not use energy stored in ATP directly. They are a membrane protein-mediated solute transport mechanism that derives its energy from the combined chemical gradients of the transported ions which are generated by Na (74) . This review will instead focus on the recent studies on the role of secondary active transport proteins in ischemia-induced dissipation of ion homeostasis. Results from both in vitro and in vivo experimental studies suggest that these ion transport proteins are potential targets to reduce or prevent ischemiamediated loss of ion homeostasis.
Na + -DEPENDENT CHLORIDE TRANSPORTER
The electroneutral NKCC protein transports Na 
NKCC1 plays a role in in vitro ischemic neuronal damage
The NKCC1 protein is expressed in neurons throughout the brain (5). It is well established that glutamate-mediated acute excitotoxic neurodegeneration is dependent on Na + and Cl -entry (6, 7). We found that in cortical neurons activation of NMDA receptors triggers a significant increase in [Na + ] i and intracellular 36 Cl content accumulation. We also showed that activation of NMDA and AMPA receptors stimulates NKCC1 activity in neurons (8). Blocking of NKCC1 activity with bumetanide abolishes the Cl -accumulation and attenuates the [Na + ] i rise by 52% (9). Bumetanide also inhibits both glutamate and NMDA-mediated cell death in cortical neurons (9). Thus, NKCC1 may act as one of the mechanisms that contribute to overload of Na + and Cl -during glutamate-mediated acute excitotoxicity (9).
It is established that oxygen-glucose deprivation (OGD)-induced neuronal death in mature neurons is mediated by NMDA receptor-triggered excitotoxicity (10). After 3 h OGD and 21 h reoxygenation (REOX), 70% of cultured cortical neurons die. OGD-mediated neuronal cell death is significantly attenuated by bumetanide, confirming the role of NKCC1 in excitotoxicity (9). Similar protection is found in cortical neurons from NKCC1 null mouse (NKCC1 -/-) following OGD (11). No additional neuroprotection is found when 10 µM bumetanide is administrated in NKCC1 -/-neuron cultures (11). These results imply that stimulation of NKCC1 activity is important in ischemic neuronal damage.
NKCC1 contributes to cell swelling, swellingmediated EAA release and cell damage of cultured astrocytes
Expression of NKCC1 protein is found in astrocytes and oligodendrocytes (5, 12, 13 homeostasis and in astrocyte death that occurs in response to hypoxia/ischemia.
NKCC1 is involved in focal cerebral ischemia
We reported that inhibition of NKCC1 activity significantly reduces infarct volume and cerebral edema following cerebral focal ischemia induced by middle cerebral artery occlusion [MCAO, (19) ]. Total NKCC1 protein expression is increased in cortex after 2 h ischemia followed by 0 , 4, 8, 12 and 24 h reperfusion of spontaneously hypertensive rats (SHR). In striatum, the significant increase is found during 4, 8, 12 and 24 h reperfusion but not at the end of 2 h ischemia. Phosphorylated NKCC1 is also increased in cortex at 4 h reperfusion and peaks at 8 h reperfusion. Because changes in phosphorylation state of NKCC1 are a major regulatory mechanism that stimulates NKCC1 activity, these findings suggest that NKCC1 may be involved in cerebral ischemic damage. When 100 µM bumetanide is continuously microdialyzed into the left cortices throughout ischemiareperfusion injury, infarct area is significantly reduced and the water content increase is decreased by 70% (19). This indicates that NKCC1 contributes to cerebral ischemic cell damage and brain edema. However, no protection is found if bumetanide is administered only during reoxygenation (19) (Yan et al, 2003) , implying that activation of NKCC1 may play a role in the early stage of ischemic damage. Administration of bumetanide (7.6-30.4 mg/kg) intravenously immediately before occlusion attenuates the decrease in apparent diffusion coefficient ratios for both cortex and striatum (by 40-67%), reflecting a reduced edema formation in rats subjected to permanent MCAO model (20) . This further suggests a role for NKCC1 in the edema formation during cerebral ischemia.
In addition to pharmacological blockage of NKCC1, we also used genetic ablation of NKCC1 to further establish that NKCC1 contributes to ischemic damage. In this study, infarct volume in NKCC1 -/-mice is reduced by ~30 to 46% (p < 0.05) at 10 h and 24 h reperfusion after 2 h MCAO (11). NKCC1 is expressed in neuronal axons, astrocytes, as well as oligodendrocytes. We further investigated the role of NKCC1 in white matter damage. Amyloid precursor protein (APP) has been suggested as a sensitive marker for axonal transport disruption in white matter during brain ischemia (21). An increase in APP occurs in NKCC1 +/+ mice after 2 h ischemia and 10 h reperfusion, but less APP accumulation is found in NKCC1 -/-mice [p < 0.05, (11)]. This implies that NKCC1 is involved in both gray and white matter damage after focal cerebral ischemia.
Na + /H + EXCHANGER
NHEs catalyze the electroneutral exchange of H + and Na + ions (1:1 stoichiometry) across cellular membranes and down their concentration gradients, thereby regulating the pH of the cytoplasm or organellar lumen (22,23). To date, nine NHE family members have been identified in mammals. NHE1-5 are expressed on the plasma membrane in various cell types. NHE6-9 reside on intracellular organellar membranes of the endosomal/trans Golgi network (22,23). NHE1 is an ubiquitously expressed plasma membrane protein and the most abundant NHE isoform in the CNS (24). NHE1 serves the crucial function of protecting cells from internal acidification. Two major classes of pharmacological agents are currently used to inhibit NHE activity. One class includes amiloride and its 5'
alkyl-substituted derivatives such as ethylisopropylamiloride (EIPA) or dimethylamiloride. Another class of inhibitors includes the derivatives of the benzoylguanidines such as HOE 694 and HOE 642. Of these, HOE 642 is the most potent one, being 10 5 times more specific for NHE1 vs. NHE3 (25).
NHE is important in neuronal damage during in vitro ischemia
A number of investigations have concluded that NHE activity in neurons is enhanced in response to ischemic/hypoxic conditions as well as during subsequent REOX. In acutely isolated CA1 neurons from NHE1 wildtype (NHE1 +/+ ) mice, 5 min chemical anoxia (induced by sodium dithionite) triggers a large alkalization that could be blocked either by the NHE1 antagonist HOE 694 or by removal of external Na + (26). The anoxia-induced alkalization is also significantly reduced in NHE1 -/-CA1 neurons. The protein kinase inhibitors chelerythrine, H-7, and H-89 significantly attenuate the increase in pH i during anoxia, suggesting that the increase in NHE1 activity involves enhanced PKA and PKC activity (26). In a similar manner, Sheldon and Church (27) observe t hat acutely isolated CA1 neurons exhibit a tri-phasic response to 5 min anoxia: an initial acidification during anoxia, an alkalization as anoxia continues, and then a further alkalization upon REOX. Removal of external Na + or reducing the external pH attenuates the post-anoxia alkalization (27). The PKA inhibitor Rp-cAMPS can block the post-anoxia alkalization in CA1 neurons which suggests involvement of cAMP-dependent signaling pathways in NHE activation. When ATP levels fall to 35% of control in isolated CA1 neurons during chemical anoxia, NHE activity is reduced by 44%. Thus, activation of NHE function appears to be dependent upon ATP energy levels which support phosphorylation of the protein (27).
When cortical neuronal cultures are subjected to the metabolic inhibitors 2-DG and KCN for 20 min, pH i decreases by 0.2 pH units, but then recovers when inhibition is removed (28). The post-inhibition pH i recovery is significantly reduced by the NHE1 inhibitors dimethylamiloride or harmaline. The authors concluded that there is significant increase in NHE1 activity both during and following metabolic inhibition. Metabolic inhibition in cultured cortical neurons induced by sodium azide causes an initial decrease in pH i within 2 min followed by a variable response, with roughly half the neurons alkalizing above baseline and half failing to regulate pH i (29). When NHE is blocked, either with pH o 6.6 or with EIPA, the decrease in pH i during metabolic inhibition is three times larger and none of the neurons exhibit regulation of pH i . These studies suggest that NHE1 activity is stimulated during and following metabolic inhibition.
In a recent study, we found that NHE1 is essential in pH i regulation in cultured cortical neurons in response to an internal acid load (30). In addition to intracellular proton content, activation of NHE1 activity also affects cellular Na + levels. 
NHE in ischemic glial damage
Recently, we have performed a series of studies on the role of NHE1 in ischemic astrocyte damage. We found that under nominally bicarbonate-free conditions NHE1 is the primary pH regulatory mechanism in cortical astrocytes. 2 h OGD and 2 min REOX cause pH i to fall by 0.29 pH units (31). Either inhibition of NHE1 with HOE 642 or genetic ablation of NHE1 results in a further decrease of pH i . Upon REOX, NHE1 activity is increased by ~ 1.8 fold in NHE1 +/+ astrocytes (31). In contrast, NHE1 activity is blocked in NHE1 +/+ astrocytes in the presence of HOE 642 or in NHE1 -/-astrocytes. This OGDinduced increase in NHE1 activity depends on ERK1/2 signaling pathways (32). Phosphorylated ERK1/2 signals are increased in astrocytes during 1 h OGD as well as REOX. MEK inhibitor PD-98059 blocks OGD-mediated stimulation of NHE1 (32).
Increased NHE1 activity in astrocytes following OGD may result in an intracellular Na + overload that is substantially mediated through activation of the ERK 1/2 pathways (32). We observed that 2 h OGD followed by 1 h REOX triggers a ~5-fold increase in [Na + ] i . OGD also results in astrocyte swelling by 26%. The OGD-induced increase in [Na + ] i and cell swelling are significantly reduced either with HOE 642 or in NHE1 -/-astrocytes (31).
In a more severe model of in vitro ischemia in astrocytes, cultured astrocytes were superfused with a hypoxic, acidic, ion shifted ringers (HAIR) solutions at 37°C, a condition which mimics the ionic composition of the ischemic extracellular space (33,34). Exposure to HAIR causes a rapid decline in astrocyte pH i that the cells failed to regulate. This is consistent with the finding that NHE1 activity is inhibited by low pH o (35). Upon return to normal buffer, astrocytes rapidly alkalize and pH i substantially overshoot the baseline suggesting a role for NHE1 (34 Post-ischemic REOX triggers a significant elevation of NHE1 activity which perturbs Na + homeostasis and leads to astrocyte death.
NHE in focal ischemia
Substantial . These studies firmly demonstrate the dominant role of NHE1 among other NHE isoforms in cerebral ischemic brain damage. This view is supported by the finding that NHE1 is the most abundant NHE isoform in the CNS (37).
SM -20220
(N-(aminoiminomethyl)-1-methyl-1H-indole-2-carboxamide methanesulfonate), a highly selective NHE inhibitor, given intravenously 1 h after MCAO significantly reduces the extent of cerebral edema and Na + content after 2 h ischemia and 4 h reperfusion and infarct volume after 22 h reperfusion (38). SM -20220 (1.0 mg/kg, iv) decreases infarct size in both transient and permanent MCAO models. Especially, there is a reduction of infarct size when the treatment is delayed for 5, 30, or 60 min after the onset of ischemia. This suggests that SM -20220 may be useful for stroke treatments (39). SM -20220-mediated protection was further evaluated after MCA thrombotic occlusion using a bolus injection of the drug just at the onset of the occlusion, followed immediately by 2. (49) demonstrate that EIPA not only protects gerbil hippocampal neuron from ischemic injury but also significantly reduces the magnitude of the ischemia-induced increase in locomotor activity at both 24 h and 6 days reperfusion. Ischemic injury to the gerbil forebrain produces an increase in locomotor activity which is related to the degree of neuronal damage in the CA1 region of the hippocampus (50).
Na + /Ca 2+ EXCHANGER
The plasma membrane NCX is widely distributed in the central nervous system. NCX works bidirectionally depending on [Na + ] i , [Ca 2+ ] i and plasma membrane potential. Normally, NCX extrudes 1 Ca 2+ ion in exchange for an influx of 3 Na + ions (51). Under physiological conditions, the NCX is thought to primarily pump Ca 2+ to the outside of the cell using the Na + concentration gradient across the cell membrane. In contrast, under special conditions in which Na + accumulates inside the cell, the NCX can transport Ca 2+ influx (reverse mode-operation of NCX). There are 3 isoforms in the NCX family [NCX1, NCX2, and NCX3, (52)]. The NCX1 gene is expressed in several tissues, including brain, heart, skeletal muscle etc., while NCX2 and NCX3 are expressed mainly in the brain and skeletal muscle (53). The interested reader can refer to the recent and extensive review on NCX by Annunziato and colleagues (54).
Role of NCX in ischemic neuronal damage
It has been reported that reversal of NCX is an important contributor to the early increase in [ Although the physiological significance of tissuespecific isoforms NCX2 and NCX3 is unclear, Bano et al. (61) recently report that NCX3, but not NCX1 and NCX2, is cleaved in cerebellar granule cells (CGN) following glutamate-induced excitotoxicity.
The delayed Ca 2+ deregulation and death in CGNs are exacerbated when NCX3 is down-regulated by siRNA. This suggests that there are differential changes among the three NCX isoforms in response to excitotoxicity/ischemia and NCX3-driven neuronal Ca 2+ extrusion is critical for CGN survival following glutamate-mediated damage.
NCX contributes to ischemic white matter and glial damage
The role of NCX exchange in axonal damage in central myelinated white matter tracts is well documented (62) .
During a noxia or trauma, intra-axonal Na + increases via activation of voltage-gated Na + channels, which promotes NCX reversal and leads to a detrimental Ca 2+ overload. The compound action potentials of rat spinal dorsal columns are preserved following either 60 min anoxic perfusion or compression injury when either bepridil or KB-R79473 is present (63) . In studies using spinal root myelinated axons, bepredil could protect from morphological degradation induced by the free radical nitric oxide (64) . These findings suggest that Ca 2+ overload via altered NCX activity is an important cause of excitotoxic and ischemic white matter damage. 
NCX in cerebral ischemia
However, the role of NCX in cerebral ischemia is conflicting. NCX reversal selective inhibitor SEA0400 is neuroprotective in rat cerebral cortex and striatum after a transient focal ischemia (66) . SEA0400 (3 mg/kg bolus, iv. plus 2 h continuous infusion at 3 mg/kg/h) reduces infarct volume >50% in cortex. In addition, topically applying KB-R7943 onto rat cerebral cortex prior to and during ischemia in rats attenuates free f atty acid (FFA) efflux which may be by reducing the activity of a specific isoform of phospholipase A2 (PLA 2 ) (67). FFA accumulation plays a role in the severity of cerebral ischemic damage (68) . KB-R7943 (10 microg/kg , icv) infused by an osmotic minipump for 24 h from the beginning of pMCAO causes a reduction of the ischemic volume (69) . However, in addition to NCX inhibition, KB-R7943 might protect cells partly through its remarkable and prolonged hypothermic effect in brains (69).
In contrast, Tortiglione et al. (70) report that during permanent ischemic injury, increased activation of NCX in a reversed mode may be neuroprotective, whereas its pharmacological blockade can exacerbate brain injury. They found all NCX inhibitors, such as tyrosine-6 glycosylated form of the exchanger inhibitory peptide (GLU-XIP), benzamil derivative (CB-DMB) and bepridil cause a worsening of the brain infarct lesion; however, FeCl 3 , a forward NCX activator, is able to reduce the extension of infarct volume. These results are interpreted by the investigators as follows. In the penumbral region, where the Na + /K + -ATPase activity is still preserved, NCX may likely operate in a forward mode, and therefore, the inhibition of NCX in this area may lead to Ca 2+ -induced cell injury by reducing the extrusion of Ca 2+ . In contrast, as the Na + /K + -ATPase activity is reduced in the ischemic core region, accumulation of Na + may lead to NCX in the reverse mode. The inhibition of NCX further worsens the necrotic lesion of the surviving glial and neuronal cell as the loading of intracellular Na + increase (69, 70) . However, it is paradoxical as to why reduced Ca 2+ influx via inhibiting the reversal of NCX in the latter condition is not neuroprotective.
NCX1, NCX2, and NCX3 isoforms are differentially expressed in distinct regions of the CNS and may not be involved in the physiological and pathophysiological functions in the same manner (53). Boscia et al (71) found that the pattern of post-ischemic NCX1, NCX2 and NCX3 gene expression varies depending on the region involved in the insult. In the ischemic core, all three NCX transcripts are down-regulated. In the periinfarct area, NCX2 mRNA is down-regulated, whereas NCX3 mRNA is significantly up-regulated. In remote nonischemic brain regions, both NCX1 and NCX3 are upregulated, whereas NCX2 signal is strongly decreased. Knockout of NCX1, NCX2 and NCX3 genes with antisense approaches show that NCX1 and NCX3 play a major protective role in the development of permanent focal cerebral ischemia (73) . After MCAO ischemia and 24 h reperfusion NCX3 is cleaved into two fragments of about 58-60 kDa in both cortex and striatum. NCX1 is only partly degraded and NCX2 is not cleaved (61).
SUMMARY
In summary, results from both in vitro and in vivo experimental studies suggest that NKCC1, NHE, and NCX play a role in ischemic cell damage. Although NCX1-mediated Ca 2+ overload in myocardial ischemia/reperfusion is known to cause myocardial cell injury (72) , studies on NCX in in vivo cerebral ischemic damage show conflicting results. This suggests that functions of NCX in the pathogenesis of cerebral ischemia are complex. Further study is needed to clarify the exact role of each NCX isoform in cerebral ischemia. Isoform specific inhibitors are needed. These ion transport proteins are potential targets to reduce or prevent ischemia-mediated loss of ion homeostasis.
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